Correlation Between Multicell Techs and Regen BioPharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Multicell Techs and Regen BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Multicell Techs and Regen BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Multicell Techs and Regen BioPharma, you can compare the effects of market volatilities on Multicell Techs and Regen BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Multicell Techs with a short position of Regen BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Multicell Techs and Regen BioPharma.

Diversification Opportunities for Multicell Techs and Regen BioPharma

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Multicell and Regen is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Multicell Techs and Regen BioPharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regen BioPharma and Multicell Techs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Multicell Techs are associated (or correlated) with Regen BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regen BioPharma has no effect on the direction of Multicell Techs i.e., Multicell Techs and Regen BioPharma go up and down completely randomly.

Pair Corralation between Multicell Techs and Regen BioPharma

If you would invest  8.99  in Regen BioPharma on September 12, 2024 and sell it today you would lose (1.49) from holding Regen BioPharma or give up 16.57% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy98.44%
ValuesDaily Returns

Multicell Techs  vs.  Regen BioPharma

 Performance 
       Timeline  
Multicell Techs 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Multicell Techs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Multicell Techs is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Regen BioPharma 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Regen BioPharma are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak fundamental drivers, Regen BioPharma reported solid returns over the last few months and may actually be approaching a breakup point.

Multicell Techs and Regen BioPharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Multicell Techs and Regen BioPharma

The main advantage of trading using opposite Multicell Techs and Regen BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Multicell Techs position performs unexpectedly, Regen BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regen BioPharma will offset losses from the drop in Regen BioPharma's long position.
The idea behind Multicell Techs and Regen BioPharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world